Prosight Management’s CVS Health CVS Stock Holding History

Prosight Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-40,000	Closed	-$2.36M	–	50
2024 Q2	$2.36M	Buy	+40,000	New	+$2.5M	0.71%	29

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Prosight Management's CVS Position: Q3 2024 in Review

Prosight Management sold out of CVS Health (CVS) in Q3 2024, closing a stake of 40,000 shares — an estimated $2.36M sold.

Prosight Management first reported a position in CVS in Q2 2024 and held it in 1 quarter. The position peaked at $2.36M in Q2 2024. 1,843 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Prosight Management reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Prosight Management sold 40,000 CVS Health shares in Q3 2024, an estimated $2.36M.
Prosight Management first reported a position in CVS Health in Q2 2024 and held it in 1 quarter.
Prosight Management's CVS Health position peaked at $2.36M in Q2 2024.
1,843 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Prosight Management's 13F filing for Q3 2024, filed 14 Nov 2024.